REGENXBIO · 6 months ago
Senior Medical Science Liaison - DMD/Neuromuscular (Midwest/West Coast)
United States
Full-time
Remote
Mid, Senior Level
$170K/yr - $230K/yr
3+ years expREGENXBIO is an exceptional place to work, aiming to bring core values of Trust, Accountability, Perseverance, and Innovation to life. As a Senior Medical Science Liaison, you will support Rare Disease pre-commercial clinical trials, focusing on the Duchenne Muscular Dystrophy program, while building networks and engaging with key opinion leaders.
BiopharmaBiotechnologyGeneticsTherapeutics
Responsibilities
Support clinical trial recruitment and site outreach; communicate coordinated feedback to the Clinical Operations, Clinical Development, and Duchenne Core teams
Serve as the field-based Medical Affairs representative to establish and cultivate scientific relationships with KOLs in the Duchenne community
Develop a strong understanding of clinical practice as it relates to Duchenne
Participate in refining KOL mapping; develop and execute on a customer-centric tactical engagement plan to support Medical Affairs strategies
Gather and share scientific insights via scientific exchange to inform executable and innovative Medical Affairs strategies
Serve as a resource for addressing unsolicited medical questions about REGENXBIO’s trials and investigational products
Provide clinical expertise in the development, management, and maintenance of clinical and scientific communications, including educational materials, meeting presentations and FAQs
Attend medical conferences as MA representative: assist with congress strategy / planning, medical booth staffing, competitive intelligence / insights gathering, and generating meeting summaries
Support Patient Advocacy conferences and outreach as requested
As a field-based position, you must be able to travel 50-70% of the time
Qualification
Required
Master's degree (MPH or equivalent) required
Minimum of 3 years of rare disease clinical or therapeutic experience in neuromuscular diseases, and/ or gene therapy with primary emphasis on field based scientific exchange and/or clinical trial support
Superior communication, relationship building and interpersonal skills
Ability to assimilate new clinical data quickly
Proactive problem-solving skills
Project management and medical writing skills
Flexibility, resilience, and creativity/ innovation in their work
Ability to organize and lead high level projects
Ability to proactively predict issues and solve problems
Ability to work collaboratively with cross-functional teams
Preferred
Doctorate level (MD, PharmD, PhD) preferred
Benefits
Annual bonus program
Education assistance
Retirement plan with employer match
Stock options at all levels
Summer hours
Company
REGENXBIO
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$928.19MKey Investors
Vivo Capital
2025-05-19Post Ipo Debt· $150M
2024-03-06Post Ipo Equity· $140M
2021-01-06Post Ipo Equity· $230.3M
Leadership Team
Curran Simpson
President and CEO
Francesca Cook
Vice President, Global Pricing and Market Access
Recent News
2026-01-16
Longevity.Technology
2026-01-16
Company data provided by crunchbase